Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 746-749, 2006. First published February 9, 2006; 10.1373/clinchem.2005.061267
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.061267v1
52/4/746    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doi, S. A.R.
Right arrow Articles by Al-Shoumer, K. A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doi, S. A.R.
Right arrow Articles by Al-Shoumer, K. A.S.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:746-749.)
© 2006 American Association for Clinical Chemistry, Inc.

Technical Briefs

Relationship between Cortisol Increment and Basal Cortisol: Implications for the Low-Dose Short Adrenocorticotropic Hormone Stimulation Test

Suhail A.R. Doi1,a, Ibrahim Lasheen2, Khaldoon Al-Humood2 and Kamal A.S. Al-Shoumer1

(Divisions of1 Endocrinology and 2 Medicine, Mubarak Al Kabeer Teaching Hospital, Jabriya, Kuwait;

aaddress correspondence to this author at: Division of Endocrinology, Mubarak Al Kabeer Teaching Hospital, PO Box 64849 Shuwaikh, 70459 Kuwait; fax 44-709-2377990, e-mail sardoi{at}gmx.net)


Abstract

Background: We analyzed the low-dose (1 µg) rapid adrenocorticotropic hormone test (LDST) in 17 patients with a normal hypothalamic-pituitary-adrenal axis to determine reference intervals for the LDST on the basis of poststimulation cortisol increments.

Methods: We analyzed test results for 17 patients (14 females and 3 males; age range, 18–46 years) who had received a 2-mL aliquot of low-dose (1 µg) adrenocorticotropic hormone prepared from one 250-µg vial of Synacthen diluted in 500 mL of sterile normal saline solution. Sampling took place at 0, 20, 30, and 60 min post stimulation. The cortisol increment was plotted against basal cortisol.

Results: We observed a marked interdependence of the basal cortisol concentration with the increase in cortisol concentration. The relationship was inverse and linear with the best fit observed at 30 min post stimulation. The lower 95% prediction limit for basal cortisol at the zero increment was 400 nmol/L with a mean concentration of 600 nmol/L.

Conclusions: We propose that a peak cortisol concentration <400 nmol/L is a sufficient single criterion for abnormal adrenal function as assessed by the LDST. Concentrations of 400–600 nmol/L are in the gray area, and those >600 nmol/L confirm normal adrenal function. Repeat analyses with larger sample sizes are warranted to confirm these observations.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.